Clinical Trials Browser

Phase 2 × Lung Neoplasms × regorafenib × Clear all

NCT04701476 2024-11-22

TATE and Pembrolizumab (MK3475) in mCRC and NSCLC

Phase 2 Recruiting

GastrointestinalThoracic

Lung Neoplasms, Colorectal Neoplasms